Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults
Clinical trial NCT03382405 · COMPLETED
Trial details
- NCT number
- NCT03382405
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2020-10-28
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.